Expanded HIV Testing in Primary Care CME

Author Information and Disclosures

Release Date: March 31, 2008; Valid for credit through March 31, 2009

Credits Available
Physicians - maximum of 1.5 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

  1. Expanded HIV Testing in Primary Care: Implementing the CDC RecommendationsDr. Bernard M. Branson discusses the rationale for the CDC guidelines for expanded HIV testing in the primary care setting and outlines strategies for their implementation.Bernard M. Branson, MD (Clinical Review, March 2008)
  2. HIV Opt-out Testing and Primary Care Practice: An Expert Interview With Kenneth H. Mayer, MDDr. Mayer provides an update and perspective on the CDC's newly revised recommendations for HIV testing.Kenneth H. Mayer, MD (Expert Interview, March 2008)
  3. HIV Testing in Primary Care: Applying New CDC GuidelinesDr. John Bartlett discusses the initial approach to 3 patients in the primary-care setting.John G. Bartlett, MD (Clinical Case, March 2008)

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Gilead
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Employ the latest epidemiologic and impact data in regard to HIV testing and recognition
  2. Discuss the role of primary care practitioners in implementing and overseeing HIV testing
  3. Describe the CDC's new recommendations for HIV screening and the rationale underpinning changes
Authors and Disclosures

Bernard M. Branson, MD
Disclosure: Bernard M. Branson, MD, has disclosed no relevant financial relationships.


Kenneth H. Mayer, MD
Disclosure: Kenneth H. Mayer, MD, has disclosed that he has received grants for clinical research from Gilead and Merck and has received grants for educational activities from Gilead, Merck, and Pfizer.


John G. Bartlett, MD
Disclosure: John G. Bartlett, MD, has disclosed that he has served on the HIV Advisory Board for Abbott, GlaxoSmithKline, Tibotec, Bristol-Myers Squibb, and Pfizer. Dr. Bartlett has also disclosed that he has served on the policy board for Johnson & Johnson.


David Danar, MD
Disclosure: David Danar, MD, has disclosed that he owns a small quantity of Pfizer Inc stock.


Thomas Maxwell Mundy, MD
Disclosure: Thomas Maxwell Mundy, MD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.